Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells

Cancer Immunology Immunotherapy

Volumn 48, Issue 12, 2000, Pages 673-683

  Shan, Daming ^a   Ledbetter, Jeffrey A ^b   Press, Oliver W ^a,c,d  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Xcyte Therapies Inc   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Apoptosis; CD20; Immunotherapy; Lymphomas; Mechanisms

Indexed keywords

CALCIUM ION; CASPASE; FC RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; RITUXIMAB;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL MEDIATED CYTOTOXICITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR REGRESSION;

EID: 0034104375     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050016     Document Type: Article

References (64)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171
2. An S, Knox KA (1996) Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett 386:115
3. An S, Yap D, Knox KA (1997) Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells Cell Immunol 181:139
4. Barber DL, D'Andrea AD (1994) Erythropoietin and interleukin-2 activate distinct JAK kinase family members. Mol Cell Biol 14:6506
5. Beiske K, Clark EA, Holte H, Ledbetter JA, Smeland EB, Godal T (1988) Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets. Int J Cancer 42:521
6. Benoit NE, Wade WF (1996) Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin. Immunopharmacology 35:129
7. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441
8. Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS (1992) Therapy with unlabeled and I-131-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts. Cancer Res 52:6478
9. Carafoli E (1987) Intracellular calcium homeostasis. Annu Rev Biochem 56:395
10. Chaouchi N, Vazques A, Galanaud P, Leprince C (1995) B cell Antigen Receptor-mediated apoptosis: importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol 154:3096
11. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM (1996) Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271:4573
12. Clark EA, Shu G, Ledbetter JA (1985) Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci USA 82:1766
13. Constantinou A, Huberman E (1995) Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 208:109
14. Deans JP, Schieven GL, Shu GL, Valentine MA, Gilliland LA, Aruffo A, Clark EA, Ledbetter JA (1993) Association of tyrosine and serine kinases with the B cell surface antigen CD20: Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C-gamma 1 and PLC phospholipase C-gamma 2. J Immunol 151:4494
15. Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P (1995) Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20: Evidence against involvement of the cytoplasmic regions of CD20. J Biol Chem 270:22632
16. Debatin KM, Beltinger C, Bohler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K (1997) Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction. Biochem Soc Trans 25:405
17. Demidem A, Lam T, Alas S, Hariharan K, Hanna H, Bonavida B (1997) Chimeric anti-CD20 antibody (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 12:177
18. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438
19. Dowd DR (1995) Calcium regulation of a poptosis. Adv Second Messenger Phosphoprotein Res 30:255
20. Ellis RE, Yuan JY, Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663
21. Evans CA, Owen-Lynch PJ, Whetton AD, Dive C (1993) Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Res 53:1735
22. Fried J, Perez AG, Clarkson BD (1978) Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures: some pitfalls in staining and data analysis. J Histochem Cytochem 26:921
23. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK, Murphy WJ (1994) Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 83:2787
24. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265
25. Hale AJ, Smith CA, Sutherlan LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT (1996) Apoptosis: molecular regulation of cell death. Eur J Biochem 236:1
26. Hooijberg E, Sein JJ, vanden Berk PC, Hart AA, vander Valk MA, Kast WM, Melief CJ, Hekman A (1995) Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Res 55:2627
27. Hug H (1997) Fas-mediated apoptosis in tumor formation and defense. Biol Chem 378:1405
28. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444
29. Juin P, Pelletier M, Oliver L, Tremblais K, Gr'egoire M, Meflah K, Vallette FM (1998) Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 273:17 559-17 564
30. Kaminski MS, Zasadny KR, Francis IR, Milik AW, Ross CW, Moon SD, Crawford SM, Burgess JM, Petry NA, Butchko GM, Glenn SD, Wahl RL (1993) Radioimmunotherapy of B-cell lymphoma with I-131-anti-B1 (anti-CD20) antibody. N Engl J Med 329:459
31. Kaminski MS, Zasadny KR, Francis IR, Fenner MC, Ross CW, Milik AW, Estes J, Tuck M, Regan D, Fisher S, Glenn SD, Wahl RL (1996) Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol 14:1974
32. Knox KA, Finney M, Milner AE, Gregory CD, Wakelam MJ, Michell RH, Gordon J (1992) Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. Int J Cancer 52:959
33. Lee YJ, Galoforo SS, Berns CM, Tong WP, Kim HR, Corry PM (1997) Glucose deprivation-induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and bcl-2 in apoptotic cell death. J Cell Sci 110:681
34. + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153:1687
35. Maloney DG, Smith BR, Appelbaum FR (1996) The anti-tumor effect of monoclonal anti-CD20 antibody (mAb) therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma (NHL) cell lines (abstract). Blood 88:637a
36. Maloney DG, Grillo-L'opez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188
37. McConkey DJ, Orrenius S (1995) Calcium and cyclosporin A in the regulation of apoptosis. Microbiol Immunol 200:95
38. McConkey DJ, Orrenius S (1996) The role of calcium in the regulation of apoptosis. J Leukoc Biol 59:775
39. Nagata S (1997) Apoptosis by death factor. Cell 88:355
40. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271
41. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709
42. Palumbo GA, Yarom N, Gazit A, Sandalon Z, Baniyash M, Kleinberger-Doron N, Levitzki A, Ben-Yehuda D (1997) The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res 57:2434
43. Press OW, Appelbaum F, Ledbetter JA, Martin PJ, Zarling J, Kidd P, Thomas ED (1987) Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 69:584
44. Press OW, Hansen JA, Farr A, Martin PJ (1988) Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes. Cancer Res 48:2249
45. Press OW, Eary JE, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, utchko G, Fisher D, Porter B, Matthews DC, Gooley T, Bernstein ID (1993) Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329:1219
46. Press OW, Howell-Clark J, Anderson S, Bernstein I (1994) Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood 83:1390
47. Press OW, Eary JE, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, Fisher DR, Porter B, Matthews DC, Gooley T, Bernstein ID (1995) Phase II trial of I-131-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 346:336
48. Rabinovitch PS, June CH, Grossmann A, Ledbetter JA (1986) Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol 137:952
49. Rao L, White E (1997) Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev 7:52
50. Reed JC (1998) Dysregulation of apoptosis in Non-Hodgkin's lymphomas: toward a molecular understanding of Bcl-2. Adv in Leukemia Lymphoma 7:1
51. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435
52. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557
53. Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK, Freidman SM (1996) CD34(+) T-cell induction of fas-mediated apoptosis in Burkitt's lymphoma B cells. BLOOD. Blood 88:1375
54. Shan D, Ledbetter JA, Press OW (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91:1644
55. Shi L, Nishioka WK, Th'ng J, Bradbury E, M., Litchfield DW, Greenberg AH (1994) Premature p34cdc2 activation required for apoptosis. Science 263:1143
56. Somma MMD, Nuti S, Telford JL, Baldari CT (1995) p56lck plays a key role in transducing apoptotic signals in T cells. FEBS Lett 363:101
57. Tedder TF, Engel P (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 15:450
58. Trauth BC, Klas C, Peters AM, Matzku S, P. M, Falk W, Debatin KM, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301
59. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T (1996) BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096
60. Vuist WM, Levy R, Maloney DG (1994) Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein. Blood 83:899
61. Wu Y, Pani G, Siminovitch K, Hozumi N (1995) Antigen receptor-triggered apoptosis in immature B cell lines is associated with the binding of a 44-kDa phosphoprotein to the PTP1 C tyrosine phosphatase. Eur J Immunol 25:2279
62. Yao K, Cooper GM (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003
63. Yao XR, Scott DW (1993) Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc Natl Acad Sci USA 90:7946
64. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641